Jushi Holdings (JUSH.F) Stock Overview
Engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
JUSH.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Jushi Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.46 |
| 52 Week High | US$0.98 |
| 52 Week Low | US$0.30 |
| Beta | 0.86 |
| 1 Month Change | -6.85% |
| 3 Month Change | -13.89% |
| 1 Year Change | 45.28% |
| 3 Year Change | 1.95% |
| 5 Year Change | -91.84% |
| Change since IPO | -81.51% |
Recent News & Updates
JUSH.F: DEA Schedule III Registration Framework Will Support Stronger Future Earnings Multiple
Analysts have kept their $1.50 price target on Jushi Holdings unchanged, citing only modest tweaks to assumptions on discount rate, profit margin and future P/E that did not materially shift their valuation view. What's in the News for Jushi Holdings Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the new federal framework following the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.JUSH.F: DEA Registration Pathway Will Support Stronger Future Earnings Multiple
Analysts have reiterated a $1.50 price target for Jushi Holdings, with slightly refined assumptions around discount rate, revenue growth, profit margin and future P/E that keep their overall valuation view broadly unchanged. What's in the News Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the federal framework that follows the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
Rescheduling Uncertainty And Heavy Debt Will Pressure Cannabis Expansion Before Potential Upside
Catalysts About Jushi Holdings Jushi Holdings operates state licensed cannabis cultivation, processing and retail facilities across several U.S. markets. What are the underlying business or industry changes driving this perspective?JUSH.F: Higher Revenue Outlook Will Support Stronger Earnings Multiple
Analysts now see fair value for Jushi Holdings at $1.50, compared with the prior $1.00. This reflects updated assumptions for revenue growth, profit margins, discount rate, and future P/E that shift their risk and earnings outlook for the stock.Recent updates
JUSH.F: DEA Schedule III Registration Framework Will Support Stronger Future Earnings Multiple
Analysts have kept their $1.50 price target on Jushi Holdings unchanged, citing only modest tweaks to assumptions on discount rate, profit margin and future P/E that did not materially shift their valuation view. What's in the News for Jushi Holdings Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the new federal framework following the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.JUSH.F: DEA Registration Pathway Will Support Stronger Future Earnings Multiple
Analysts have reiterated a $1.50 price target for Jushi Holdings, with slightly refined assumptions around discount rate, revenue growth, profit margin and future P/E that keep their overall valuation view broadly unchanged. What's in the News Jushi Holdings submitted applications to the U.S. Drug Enforcement Administration for registration of certain state licensed medical marijuana operations under the federal framework that follows the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.Rescheduling Uncertainty And Heavy Debt Will Pressure Cannabis Expansion Before Potential Upside
Catalysts About Jushi Holdings Jushi Holdings operates state licensed cannabis cultivation, processing and retail facilities across several U.S. markets. What are the underlying business or industry changes driving this perspective?JUSH.F: Higher Revenue Outlook Will Support Stronger Earnings Multiple
Analysts now see fair value for Jushi Holdings at $1.50, compared with the prior $1.00. This reflects updated assumptions for revenue growth, profit margins, discount rate, and future P/E that shift their risk and earnings outlook for the stock.
Adult Use Legalization And Rescheduling Will Reshape Long Term Prospects For This Cannabis Operator
Catalysts About Jushi Holdings Jushi Holdings is a vertically integrated cannabis company focused on retail, cultivation and processing across several U.S. medical and emerging adult use markets. What are the underlying business or industry changes driving this perspective?
Pennsylvania And Virginia Retail And Canopy Expansion Will Open Markets
Expanding retail and canopy space aims to enhance revenue, anticipating market growth from potential adult-use cannabis legalization.Shareholder Returns
| JUSH.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -4.1% | 1.4% | 1.6% |
| 1Y | 45.3% | 48.6% | 18.6% |
Return vs Industry: JUSH.F underperformed the US Pharmaceuticals industry which returned 48.4% over the past year.
Return vs Market: JUSH.F exceeded the US Market which returned 19.1% over the past year.
Price Volatility
| JUSH.F volatility | |
|---|---|
| JUSH.F Average Weekly Movement | 15.7% |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: JUSH.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: JUSH.F's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 1,288 | Jim Cacioppo | jushico.com |
Jushi Holdings Inc. engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States. The company offers flower, vapes, concentrates, infused chews and chocolates, tinctures, capsules, softgels, topicals and RSO, pre-rolls, and infused chocolate bites under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, Sèche, Shayo, and Carm’s Delight Bites brands. It also engages in the sale of bulk raw materials to duly licensed third parties for use in its own finished products.
Jushi Holdings Inc. Fundamentals Summary
| JUSH.F fundamental statistics | |
|---|---|
| Market cap | US$92.84m |
| Earnings (TTM) | -US$71.42m |
| Revenue (TTM) | US$265.50m |
Is JUSH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JUSH.F income statement (TTM) | |
|---|---|
| Revenue | US$265.50m |
| Cost of Revenue | US$147.42m |
| Gross Profit | US$118.08m |
| Other Expenses | US$189.50m |
| Earnings | -US$71.42m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.36 |
| Gross Margin | 44.47% |
| Net Profit Margin | -26.90% |
| Debt/Equity Ratio | -171.6% |
How did JUSH.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/04 05:41 |
| End of Day Share Price | 2026/07/02 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jushi Holdings Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Luke Hannan | Canaccord Genuity |
| Sonny Randhawa | Seaport Research Partners |